U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Octreotide Acetate Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology; Oncology

Expand all

Teva (New 08/11/2022)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
NDC 0703-3343-01 (5000 mcg/5 mL (1000 mcg/mL) 5 mL Multiple Dose Vial) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
NDC 0703-3321-04 (500 mcg/mL, 25 x 1 mL Single Dose Vials) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
NDC 0703-3333-01 (1000 mcg/5 mL (200 mcg/mL) 5 mL Multiple Dose Vial) 08/11/2022 Product is available with an expected supply duration until JUL 2022. No future production expected for an extended period.
NDC 0703-3311-04 (100 mcg/mL 1 mL Single Dose Vial 25 Vials) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
NDC 0703-3301-04 (50 mcg/mL 1 mL Single Dose Vial 25 Vials) 08/11/2022 Product is currently unavailable and no future production expected for an extended period.
Back to Top